Douglas H. Sweet

4.8k total citations
63 papers, 3.9k citations indexed

About

Douglas H. Sweet is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Douglas H. Sweet has authored 63 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 21 papers in Pediatrics, Perinatology and Child Health and 19 papers in Molecular Biology. Recurrent topics in Douglas H. Sweet's work include Drug Transport and Resistance Mechanisms (42 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Metabolism and Genetic Disorders (10 papers). Douglas H. Sweet is often cited by papers focused on Drug Transport and Resistance Mechanisms (42 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Metabolism and Genetic Disorders (10 papers). Douglas H. Sweet collaborates with scholars based in United States, Germany and Taiwan. Douglas H. Sweet's co-authors include John B. Pritchard, Li Wang, David S. Miller, Adam L. VanWert, Natascha A. Wolff, Sanjay K. Nigám, Geri L. Youngblood, Michael R. Gionfriddo, Ramsey Walden and Kevin T. Bush and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cell Metabolism.

In The Last Decade

Douglas H. Sweet

63 papers receiving 3.8k citations

Peers

Countries citing papers authored by Douglas H. Sweet

Since Specialization

Citations

This map shows the geographic impact of Douglas H. Sweet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas H. Sweet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas H. Sweet more than expected).

Fields of papers citing papers by Douglas H. Sweet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas H. Sweet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas H. Sweet. The network helps show where Douglas H. Sweet may publish in the future.

Co-authorship network of co-authors of Douglas H. Sweet

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas H. Sweet. A scholar is included among the top collaborators of Douglas H. Sweet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas H. Sweet. Douglas H. Sweet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain 2017 ·Neuropharmacology ·Kerstin Römermann, Maren Fedrowitz, (unknown), (unknown), Kathrin Töllner, Thomas Erker, Douglas H. Sweet, Wolfgang Löscher	58
2	The Furan Fatty Acid Metabolite CMPF Is Elevated in Diabetes and Induces β Cell Dysfunction 2014 ·Cell Metabolism ·Kacey J. Prentice, (unknown), Emma M. Allister, Ying Liu, Lucy S. Jun, Kyle W. Sloop, Alexandre B. Hardy, Li Wei, Weiping Jia, I. George Fantus, Douglas H. Sweet, Gary Sweeney, Ravi Retnakaran, Feihan F. Dai, Michael B. Wheeler	132
3	Cumulative Organic Anion Transporter-Mediated Drug-Drug Interaction Potential of Multiple Components in Salvia Miltiorrhiza (Danshen) Preparations 2014 ·Pharmaceutical Research ·Li Wang, Jürgen Venitz, Douglas H. Sweet	9
4	Expression and Function of Organic Cation and Anion Transporters (SLC22 Family) in the CNS 2014 ·Current Pharmaceutical Design ·Christine Farthing, Douglas H. Sweet	22
5	The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination 2013 ·Biochemical Pharmacology ·Li Wang, (unknown), Douglas H. Sweet	32
6	Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters 2012 ·Expert Opinion on Drug Metabolism & Toxicology ·Aditi Mulgaonkar, Jürgen Venitz, Douglas H. Sweet	25
7	Competitive Inhibition of Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by Major Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) 2012 ·Drug Metabolism and Pharmacokinetics ·Li Wang, Douglas H. Sweet	29
8	Linkage of Organic Anion Transporter-1 to Metabolic Pathways through Integrated “Omics”-driven Network and Functional Analysis 2011 ·Journal of Biological Chemistry ·Sun-Young Ahn, Neema Jamshidi, Monica L. Mo, Wei Wu, Satish A. Eraly, Ankur V. Dnyanmote, Kevin T. Bush, (unknown), Douglas H. Sweet, Bernhard Ø. Palsson, Sanjay K. Nigám	55
9	Organic Anion Transporter 3 (Oat3/Slc22a8) Interacts with Carboxyfluoroquinolones, and Deletion Increases Systemic Exposure to Ciprofloxacin 2008 ·Molecular Pharmacology ·Adam L. VanWert, Chutima Srimaroeng, Douglas H. Sweet	87
10	Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis 2008 ·The American Journal of Human Genetics ·Hao‐Jie Zhu, Kennerly S. Patrick, (unknown), (unknown), Jennifer L. Donovan, C. Lindsay DeVane, Robert Malcolm, Julie A. Johnson, Geri L. Youngblood, Douglas H. Sweet, Taimour Langaee, John S. Markowitz	182
11	Activation of Protein Kinase Cζ Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport 2008 ·Journal of Biological Chemistry ·Scott Barros, Chutima Srimaroeng, Jennifer L. Perry, Ramsey Walden, (unknown), Douglas H. Sweet, John B. Pritchard	40
12	Impaired Clearance of Methotrexate in Organic Anion Transporter 3 (Slc22a8) Knockout Mice: A Gender Specific Impact of Reduced Folates 2007 ·Pharmaceutical Research ·Adam L. VanWert, Douglas H. Sweet	63
13	Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G 2007 ·American Journal of Physiology-Renal Physiology ·Adam L. VanWert, Rachel M. Bailey, Douglas H. Sweet	67
14	Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models 2006 ·Kidney International ·Douglas H. Sweet, (unknown), Duke A. Vaughn, Kevin T. Bush, Sanjay K. Nigám	51
15	Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20) 2006 ·American Journal of Physiology-Renal Physiology ·(unknown), Geri L. Youngblood, Douglas H. Sweet	36
16	Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney 2004 ·American Journal of Physiology-Renal Physiology ·Geri L. Youngblood, Douglas H. Sweet	94
17	Stoichiometry of organic anion/dicarboxylate exchange in membrane vesicles from rat renal cortex and hOAT1-expressing cells 2003 ·American Journal of Physiology-Renal Physiology ·Amy G. Aslamkhan, Yong–Hae Han, Ramsey Walden, Douglas H. Sweet, John B. Pritchard	39
18	Characterization of a Novel Cationic Drug Transporter in Human Retinal Pigment Epithelial Cells 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Yong–Hae Han, Douglas H. Sweet, Dan‐Ning Hu, John B. Pritchard	60
19	Mechanism of Organic Anion Transport across the Apical Membrane of Choroid Plexus 1999 ·Journal of Biological Chemistry ·John B. Pritchard, Douglas H. Sweet, David S. Miller, Ramsey Walden	66
20	The molecular biology of renal organic anion and organic cation transporters 1999 ·Cell Biochemistry and Biophysics ·Douglas H. Sweet, John B. Pritchard	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact